Mkts

Co-Diagnostics, Inc.

NASDAQ: CODX
$0.23-0.03 (-11.25%)
As of Nov 16, 10:05 AM ET

Key statistics

Day range
0.230.25
52-week range
0.2413.54
Today
Open0.24
Previous close0.23
Volume110.3K
Valuation
Market cap2.72M
P/E ratio—
EPS (TTM)-23.84
Income & risk
Dividend / yield—
Beta3.31
Avg volume1.51M
Discussion

CODX News

Stories mentioning CODX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue146.00264.00145.00163.0050.00149.00641.002,657
Cost of Goods Sold194.00142.0026.0032.0022.00255.00297.00212.00
Gross Profit(48.00)121.00119.00131.0029.00(106.00)344.002,445
Operating Expenses
Research & Development5,9345,0994,4814,6874,8704,8074,8805,613
Sales General & Admin
Total Operating Expenses9,16126,6627,1338,1898,58111,80010,57910,125
Operating Income (Loss)(9,208)(26,541)(7,014)(8,058)(8,552)(11,907)(10,235)(7,680)
Interest Income
Interest Expense
Other Expense
Pretax Income(9,140)(26,220)(7,053)(7,718)(7,521)(11,040)(9,674)(7,579)
Tax Provision1.00(473.00)(1,167)12.0012.00(9.00)22.0021.00
Net Income (Loss)(9,140)(25,746)(5,887)(7,730)(7,533)(11,032)(9,696)(7,599)
Earnings Per Share (Basic)(4.06)(19.36)(0.16)(0.23)(7.05)(10.91)(0.32)(0.25)
Earnings Per Share (Diluted)(4.06)(19.36)(0.16)(0.23)(7.05)(10.91)(0.32)(0.25)
Weighted Average Shares Outstanding (Basic)2,2531,33037,89133,1081,0681,01130,49430,125
Weighted Average Shares Outstanding (Diluted)2,2531,33037,89133,1081,0681,01130,49430,125

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CODX

Co-Diagnostics, Inc. (NASDAQ: CODX) is a stock listed on the Nasdaq Stock Market under the ticker symbol CODX. It last traded at $0.2300 (Nov 16, 2026, 10:05 AM ET), down 11.3% on the day. That gives Co-Diagnostics a market capitalisation of $2.7M.

Over the past 52 weeks CODX has traded between $0.2400 and $13.54.

Revenue for the quarter ended Mar 31, 2026 was $146.0K; a net loss of $9.1M. Revenue was up 192% from $50.0K in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$146.0K-$9.1M-6260.3%
Dec 31, 2025$264.0K-$25.7M-9752.3%
Sep 30, 2025$145.0K-$5.9M-4060.0%
Jun 30, 2025$163.0K-$7.7M-4742.3%

From Co-Diagnostics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…